Literature DB >> 31949330

Antioxidative enzyme activity and total antioxidant capacity in serum of dogs with degenerative mitral valve disease.

Marcin Michałek1, Aleksandra Tabiś1, Alicja Cepiel1, Agnieszka Noszczyk-Nowak1.   

Abstract

This study was designed to evaluate the antioxidative status of serum by measuring its total antioxidant capacity, as well as the antioxidant enzyme activity (superoxide dismutase, catalase, and glutathione reductase), in dogs with various stages of degenerative mitral valve disease (DMVD) compared to healthy controls. In total, 71 client-owned dogs in different stages of DMVD, which included healthy controls, took part in the study. Following an anamnesis, clinical examination, standard transthoracic echocardiograpic examination, chest X-ray, complete blood (cell) count, and serum biochemistry, dogs were divided into 2 study groups. Blood was drawn from each dog once at the time of presentation and selected antioxidant parameters were measured using commercially available assay kits. The activity of superoxide dismutase gradually decreased in the more advanced stages of DMVD, while the activity of catalase was significantly higher in the group of dogs with asymptomatic DMVD compared to healthy controls and dogs with symptomatic DMVD. No significant changes were noted in total antioxidant capacity and the activity of glutathione reductase. Results suggested that DMVD has a significant impact on the activity of superoxide dismutase and catalase in the serum of the tested dogs. Knowledge of changes in the activity of antioxidative enzymes may warrant further studies, possibly to evaluate the potential role of compounds with antioxidative properties in the clinical outcome of dogs with DMVD. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Year:  2020        PMID: 31949330      PMCID: PMC6923815     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  32 in total

1.  Allometric scaling of M-mode cardiac measurements in normal adult dogs.

Authors:  Craig C Cornell; Mark D Kittleson; Paul Della Torre; Jens Häggström; Christophe W Lombard; Henrik D Pedersen; Andrea Vollmar; Aaron Wey
Journal:  J Vet Intern Med       Date:  2004 May-Jun       Impact factor: 3.333

2.  Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies.

Authors:  Gemma Flores-Mateo; Paloma Carrillo-Santisteve; Roberto Elosua; Eliseo Guallar; Jaume Marrugat; Joachim Bleys; María-Isabel Covas
Journal:  Am J Epidemiol       Date:  2009-05-22       Impact factor: 4.897

3.  Guidelines for the diagnosis and treatment of canine chronic valvular heart disease.

Authors:  C Atkins; J Bonagura; S Ettinger; P Fox; S Gordon; J Haggstrom; R Hamlin; B Keene; V Luis-Fuentes; R Stepien
Journal:  J Vet Intern Med       Date:  2009-09-22       Impact factor: 3.333

4.  Diltiazem attenuates oxidative stress in diabetic rats.

Authors:  Muragundla Anjaneyulu; Kanwaljit Chopra
Journal:  Ren Fail       Date:  2005       Impact factor: 2.606

Review 5.  Mini-Review: Oxidative stress, redox stress or redox success?

Authors:  John M C Gutteridge; Barry Halliwell
Journal:  Biochem Biophys Res Commun       Date:  2018-05-24       Impact factor: 3.575

6.  Human serum catalase decreases endothelial cell injury from hydrogen peroxide.

Authors:  J A Leff; M A Oppegard; L S Terada; E C McCarty; J E Repine
Journal:  J Appl Physiol (1985)       Date:  1991-11

7.  Serum paraoxonase 1 activity and lipid metabolism parameter changes in Dachshunds with chronic mitral valve disease. Assessment of its diagnostic usefulness.

Authors:  M Kulka; M Garncarz; M Parzeniecka-Jaworska; W Kluciński
Journal:  Pol J Vet Sci       Date:  2017-12       Impact factor: 0.821

8.  Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat.

Authors:  G Chandran; K N S Sirajudeen; Nik Syamimi Nik Yusoff; M Swamy; Mutum S Samarendra
Journal:  Oxid Med Cell Longev       Date:  2014-08-28       Impact factor: 6.543

Review 9.  Beta-Blockers and Oxidative Stress in Patients with Heart Failure.

Authors:  Kazufumi Nakamura; Masato Murakami; Daiji Miura; Kei Yunoki; Kenki Enko; Masamichi Tanaka; Yukihiro Saito; Nobuhiro Nishii; Toru Miyoshi; Masashi Yoshida; Hiroki Oe; Norihisa Toh; Satoshi Nagase; Kunihisa Kohno; Hiroshi Morita; Hiromi Matsubara; Kengo F Kusano; Tohru Ohe; Hiroshi Ito
Journal:  Pharmaceuticals (Basel)       Date:  2011-08-05

Review 10.  Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update.

Authors:  Camila Peres Rubio; Josefa Hernández-Ruiz; Silvia Martinez-Subiela; Asta Tvarijonaviciute; José Joaquin Ceron
Journal:  BMC Vet Res       Date:  2016-08-15       Impact factor: 2.741

View more
  2 in total

1.  Changes of inflammatory and oxidative stress biomarkers in dogs with different stages of heart failure.

Authors:  Camila Peres Rubio; Ahmet Saril; Meriç Kocaturk; Ryou Tanaka; Jorgen Koch; Jose Joaquin Ceron; Zeki Yilmaz
Journal:  BMC Vet Res       Date:  2020-11-10       Impact factor: 2.741

2.  Effects of Coenzyme Q10 Supplementation on Oxidative Stress Markers, Inflammatory Markers, Lymphocyte Subpopulations, and Clinical Status in Dogs with Myxomatous Mitral Valve Disease.

Authors:  Natalia Druzhaeva; Alenka Nemec Svete; Gabrijela Tavčar-Kalcher; Janja Babič; Alojz Ihan; Katka Pohar; Uroš Krapež; Aleksandra Domanjko Petrič
Journal:  Antioxidants (Basel)       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.